These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 21061247)

  • 1. Outcomes of patients with acute myocardial infarction from a saphenous vein graft culprit undergoing percutaneous coronary intervention.
    Gaglia MA; Torguson R; Xue Z; Gonzalez MA; Ben-Dor I; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):23-9. PubMed ID: 21061247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.
    Brilakis ES; Lasala JM; Cox DA; Berger PB; Bowman TS; Starzyk RM; Dawkins KD
    JACC Cardiovasc Interv; 2010 Jul; 3(7):742-50. PubMed ID: 20650436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical outcomes in patients presenting with an acute coronary syndrome due to stent thrombosis or saphenous vein graft occlusion and undergoing percutaneous coronary intervention.
    Ota H; Mahmoudi M; Lhermusier T; Magalhaes MA; Torguson R; Satler LF; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2015 Dec; 16(8):441-6. PubMed ID: 26704310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion.
    Brodie BR; VerSteeg DS; Brodie MM; Hansen C; Richter SJ; Stuckey TD; Gupta N; Pulsipher M; Downey W
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):504-9. PubMed ID: 15988742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and outcome of primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction due to saphenous vein graft occlusion].
    Ergelen M; Uyarel H; Gül M; Türer A; Yıldırım E; Bozbay M; Demirci D; Ersan D; Türkkan C; Uluganyan M; Tezel T
    Turk Kardiyol Dern Ars; 2010 Dec; 38(8):531-6. PubMed ID: 21248452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
    Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
    Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: a multicenter Southern Californian Registry.
    Lee MS; Hu PP; Aragon J; Shah A; Bhatia R; Jones N; Penny W; French W; Tobis J; Mahmud E
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):272-8. PubMed ID: 20623716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
    Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis.
    Arzamendi D; Ly HQ; Tanguay JF; Armero S; Jilaihawi H; Gallo R; Ibrahim R; L'Allier P; Blondeau L; Gosselin G; Gregoire J; Doucet S
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):193-200. PubMed ID: 21805615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry.
    Brilakis ES; Rao SV; Banerjee S; Goldman S; Shunk KA; Holmes DR; Honeycutt E; Roe MT
    JACC Cardiovasc Interv; 2011 Aug; 4(8):844-50. PubMed ID: 21851896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with previous coronary bypass surgery.
    Kohl LP; Garberich RF; Yang H; Sharkey SW; Burke MN; Lips DL; Hildebrandt DA; Larson DM; Henry TD
    JACC Cardiovasc Interv; 2014 Sep; 7(9):981-7. PubMed ID: 25234670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions.
    Jeger RV; Schneiter S; Kaiser C; Bonetti PO; Brunner-La Rocca H; Handke M; Osswald S; Buser PT; Pfisterer ME;
    Cardiology; 2009; 112(1):49-55. PubMed ID: 18580059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous intervention of acutely occluded saphenous vein grafts: contemporary techniques and outcomes.
    Abdel-Karim AR; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2010 Jun; 22(6):253-7. PubMed ID: 20516502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
    Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Welsh RC; Granger CB; Westerhout CM; Blankenship JC; Holmes DR; O'Neill WW; Hamm CW; Van de Werf F; Armstrong PW;
    JACC Cardiovasc Interv; 2010 Mar; 3(3):343-51. PubMed ID: 20298996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
    Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts.
    Upadhya B; Applegate RJ; Sane DC; Deliargyris EN; Kutcher MA; Gandhi SK; Baki TT; Call JT; Little WC
    Am J Cardiol; 2005 Aug; 96(4):515-8. PubMed ID: 16098303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft.
    Mehta RH; Honeycutt E; Peterson ED; Granger CB; Halabi AR; Shaw LK; Smith PK; Califf RM; Harrington RA; Sketch MH
    Circulation; 2006 Jul; 114(1 Suppl):I396-401. PubMed ID: 16820607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
    Harskamp RE; Beijk MA; Damman P; Kuijt WJ; Woudstra P; Grundeken MJ; Kloek JJ; Tijssen JG; de Mol BA; de Winter RJ
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):438-45. PubMed ID: 22828774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.